Chemomab Therapeutics所有資訊

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(9.99%),OrbiMed Israel GP Ltd.(9.99%)等

09/17 04:37

Chemomab Therapeutics | SC 13G：超過5%持股股東披露文件-Sphera Funds Management Ltd.(6.56%),Sphera Global Healthcare GP Ltd.(6.56%)等

08/21 02:38

Chemomab Therapeutics | D：發行公告

08/10 04:43

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(16.0%),OrbiMed Israel GP Ltd.(16.0%)等

03/12 07:23

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(18.3%),OrbiMed Israel GP Ltd.(18.3%)等

2023/11/16 05:35

Chemomab Therapeutics | 4：持股變動聲明-董事 Darvish Nissim

2023/07/06 05:48

Chemomab Therapeutics | 4：持股變動聲明-董事 Quigley Jill M.

2023/06/20 18:03

Chemomab Therapeutics | 4：持股變動聲明-首席財務官 Fatal Sigal

2023/06/17 04:03

Chemomab Therapeutics | 3：首次持股聲明-首席財務官 Fatal Sigal

2023/06/06 04:54

Chemomab Therapeutics | 4：持股變動聲明-董事 Moses Alan Charles

2023/03/23 19:38

Chemomab Therapeutics | 4：持股變動聲明-董事 Nicaise Claude

2023/03/23 19:36

Chemomab Therapeutics | 4：持股變動聲明-董事 Cohen Neil Harris

2023/03/23 19:35

Chemomab Therapeutics | 4：持股變動聲明-董事 Darvish Nissim

2023/03/23 19:33

Chemomab Therapeutics | 4：持股變動聲明

2023/01/06 05:49

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Israel BioFund GP Limited Partnership(19.7%),OrbiMed Israel GP Ltd.(19.7%)

2023/01/06 05:31

Chemomab Therapeutics | 4：持股變動聲明

2023/01/06 05:01

Chemomab Therapeutics | 4：持股變動聲明

2022/11/18 20:53

Chemomab Therapeutics | 4：持股變動聲明

2022/11/18 05:56

Chemomab Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Adi Mor(6.4%),Kobi George(6.4%)

2022/11/18 05:40

Chemomab Therapeutics | 3：首次持股聲明-高管 Frankel Matthew Bejosa

2022/11/16 05:03